Condition
Pediatric SLE
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
11 treatments under study, led by Continue Is Mtx
Related Conditions
Often studied with 8 related conditions
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
100.0%
1 terminated out of 1 trials
Success Rate
0.0%
-86.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results0
Data Visualizations
Phase Distribution
1Total
Phase 2 (1)
Trial Status
Terminated1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Continue Is Mtx1
- Withhold Is B Cell Depletion Therapy1
- Bnt162b2 Bivalent1
- Monovalent B1351 Cov2 Pres Dtmas031
- Continue Is B Cell Depletion Therapy1
Active Sponsors
- Rho Federal Systems Division, Inc.1
- National Institute of Allergy and Infectious Diseases (NIAID)1
- Autoimmunity Centers of Excellence1
Top Investigators
Center for Neuroinflammation and Neurotherapeutics, Perelman School of Medicine, University of Pennsylvania
Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation
Drukier Institute for Children's Health, Weill Cornell Medical College
University of Michigan Health, Michigan Medicine
Center of Autoimmune Musculoskeletal and Hematopoietic Diseases, Feinstein Institute for Medical Research
Related Conditions
- Systemic Sclerosis Ssc1
- Juvenile Dermatomyositis Jdm1
- Pemphigus Vulgaris1
- Systemic Lupus Erythematosus Sle1
- Rheumatoid Arthritis Ra1